PATENT CLAIM ANALYSIS

Application Number: 16034710
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "055000"]

Abstract:
A task of the invention is to provide an art that inhibits the hemorrhagic activity exhibited by sulfated glycosaminoglycans, as well as a material, a medical material, and a drug that use a sulfated glycosaminoglycan while being free of the hemorrhaging problems caused by sulfated glycosaminoglycans and that can exhibit an excellent therapeutic effect on biological tissues. The present invention relates to an inhibitor of the hemorrhagic activity originating from sulfated glycosaminoglycans, the inhibitor having a cationized chitosan as an active ingredient.

Claim (Index 4):
The method for treating a wound according to  claim 3 , wherein the quaternary chitosan is N-(2-hydroxypropyl)-3-trimethylammonium chitosan chloride.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 95.0
- Lexical Diversity: 1.62963
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11803404', '09727873', '12659656', '13823437', '11171490']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7303191667879201
- 35 USC 102 Novelty (BERT): 0.4982001462074015
- Combined Prediction Score: 0.7071072647298683
- Mean Citation Score: 189.527132
- Max Citation Score: 216.40805
- Similarity Product: 159.39398910293878

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test